Boehringer Ingelheim - Recruiting 18 years or older. - A Phase IIIb, Non-randomized, Open-label, Two-cohort Study in Patients With EGFR Mutations-positive Advanced Adenocarcinoma of the Lung, Assessing the Utility of the Afatinib Diarrhea Assessment and Management Guidelines (ADAM).
Duke University - Recruiting N/A to 83 Days. - An Open-label, Pilot Study to Compare the Safety and Immunogenicity of an Alternate Dosing Schedule (2-5 Weeks, 2 Months, and 4 Months) for Pentavalent Rotavirus Vaccine (RotaTeq) to the Standard Recommended Schedule (2, 4, and 6 Months).
Institute for OneWorld Health - Recruiting 18 years to 65 years. - Phase 2, Single Centre, Randomized, Double-blind Study Conducted in Adult Males With Acute Dehydrating Diarrhea Due to Cholera With the Aim Being to Select One or More of the Three Fermentable Starches (FS) for an FS-HO-ORS Formulation..
Children's Oncology Group - Recruiting 6 Months to 21 years. - A Randomized Trial of Levofloxacin to Prevent Bacteremia in Children Being Treated for Acute Leukemia (AL) or Undergoing Hematopoietic Stem Cell Transplantation (HSCT).
University of Southern California - Recruiting 18 years or older. - A Phase II Clinical Trial of Cabazitaxel Plus Prednisone With Octreotide in the Treatment of Castration-Resistant Prostate Cancer (CRPC) Previously Treated With Docetaxel.
Uniformed Services University of the Health Sciences - Recruiting 18 years or older. - A Randomized, Double-Blind, Clinical Trial Evaluating Three Single Dose Regimens With Loperamide for Treatment of Ambulatory Watery Travelers' Diarrhea, and Azithromycin With and Without Loperamide for Treatment of Ambulatory Dysentery/Febrile Diarrhea.
Single dose rifaximin 1650 mg; Single dose azithromycin 500 mg; Single dose levofloxacin 500 mg; Single dose azithromycin 1000 mg plus loperamide; Single dose azithromycin 1000 mg plus placebo
University of Michigan - Recruiting 18 years or older. - Comparing the Effectiveness of Two Diets to Control the Symptoms of Irritable Bowel Syndrome With Diarrhea (IBS-D): a Randomized, Controlled Trial and Gastrointestinal Microbiome Analysis.
Medical University of Warsaw - Recruiting 4 Months to 48 Months. - Efficacy and Safety of a New Oral Rehydration Solution (Hipp ORS 200 Apple) in Children With Acute Gastroenteritis: Randomized, Double-Blind Controlled Trial.
oral rehydration solution Hipp ORS Apple 200; ESPGHAN ORS